These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9823432)

  • 41. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of cisplatin resistance in human urothelial carcinoma cells.
    Yu HM; Wang TC
    Food Chem Toxicol; 2012 May; 50(5):1226-37. PubMed ID: 22326969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
    Armstrong DK; Gordon GB; Hilton J; Streeper RT; Colvin OM; Davidson NE
    Cancer Res; 1992 Mar; 52(6):1416-21. PubMed ID: 1540950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
    Sikic BI; Scudder SA; Ballon SC; Soriero OM; Christman JE; Suey L; Ehsan MN; Brandt AE; Evans TL
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities.
    Byun SS; Kim SW; Choi H; Lee C; Lee E
    BJU Int; 2005 May; 95(7):1086-90. PubMed ID: 15839938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P; Loh SY; Kelland LR; Harrap KR
    Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
    Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Quantitative analysis of glutathione and glutathione S-transferase in human brain tumors, C6 rat glioma cells and drug resistant C6 cells].
    Matsumoto Y; Sasaoka N; Tsuchida T; Fujiwara T; Nagao S
    No Shinkei Geka; 1992 Oct; 20(10):1069-74. PubMed ID: 1407341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of intracellular reduced glutathione and glutathione related enzyme activities in cisplatin-sensitive and resistant experimental ovarian carcinoma cell lines.
    Chen G; Frei E; Zeller WJ
    Cancer Lett; 1989 Aug; 46(3):207-11. PubMed ID: 2766260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
    Kotoh S; Naito S; Yokomizo A; Kumazawa J; Asakuno K; Kohno K; Kuwano M
    Cancer Res; 1994 Jun; 54(12):3248-52. PubMed ID: 8205547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
    Nishikawa K; Rosenblum MG; Newman RA; Pandita TK; Hittelman WN; Donato NJ
    Cancer Res; 1992 Sep; 52(17):4758-65. PubMed ID: 1380890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
    Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B
    Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential properties of cisplatin and tetraplatin with respect to cytotoxicity and perturbation of cellular glutathione levels.
    Müller MR; Wright KA; Twentyman PR
    Cancer Chemother Pharmacol; 1991; 28(4):273-6. PubMed ID: 1879044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients.
    Surowiak P; Materna V; Kaplenko I; Spaczyński M; Dietel M; Lage H; Zabel M
    Virchows Arch; 2005 Sep; 447(3):626-33. PubMed ID: 15968547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH; Gupta V; Singh SV
    Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.
    Welters MJ; Fichtinger-Schepman AM; Baan RA; Flens MJ; Scheper RJ; Braakhuis BJ
    Br J Cancer; 1998 Feb; 77(4):556-61. PubMed ID: 9484811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line.
    Chao CC; Huang YT; Ma CM; Chou WY; Lin-Chao S
    Mol Pharmacol; 1992 Jan; 41(1):69-75. PubMed ID: 1346333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-pi gene in human glioblastoma cells.
    Brandt TY; Ali-Osman F
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):22-9. PubMed ID: 9073588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of metallothionein in cisplatin sensitivity of germ-cell tumours.
    Meijer C; Timmer A; De Vries EG; Groten JP; Knol A; Zwart N; Dam WA; Sleijfer DT; Mulder NH
    Int J Cancer; 2000 Mar; 85(6):777-81. PubMed ID: 10709094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Esaki T; Nakano S; Masumoto N; Fujishima H; Niho Y
    Int J Cancer; 1996 Feb; 65(4):479-84. PubMed ID: 8621231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.